HIND
Vyome Holdings, Inc
+0.10 (+5.13%)2.05USD2.4K成交股數14.4M市值0.0本益比(近四季)–股價營收比-97.8%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 27K-98% | 32K-98% | 35K-98% | 1.2M-37% | 1.1M-43% | 1.8M-16% | 2.3M+2% | 2.0M-14% | 1.9M | 2.2M | 2.3M | 2.3M |
| 營業成本 | 15K | 15K | 17K | 26K | 44K | −1.6M | 47K | 831K | 779K | 867K | 1.1M | 1.1M |
| 毛利 | 12K-92% | 17K-101% | 18K-51% | 24K-98% | 154K-87% | −2.1M-266% | 37K-97% | 1.1M-7% | 1.2M | 1.3M | 1.2M | 1.2M |
| 毛利率 | 43.2% | 52.7% | 52.1% | 2.0% | 13.9% | -118.6% | 1.6% | 57.7% | 59.9% | 59.8% | 53.0% | 53.5% |
| 研發費用 | 507K | 666K | 40K | 80K | 90K | −664K | 67K | 399K | 484K | 542K | 581K | 453K |
| 銷售管理費用 | 365K | 478K | 844K | 265K | 260K | −1.0M | 247K | 670K | 1.0M | 1.8M | 2.2M | 2.2M |
| 營業利益 | −863K+333% | −1.1M-132% | −8.6M+2952% | −324K-84% | −199K-91% | 3.5M-191% | −281K-93% | −2.1M-64% | −2.2M | −3.9M | −4.0M | −5.6M |
| 營業利益率 | -3,200.0% | -3,576.8% | -24,761.9% | -26.1% | -17.9% | 196.0% | -12.3% | -104.5% | -113.7% | -180.0% | -176.4% | -246.2% |
| 稅後淨利 | −686K+133% | −963K-133% | −8.4M+1440% | −309K-81% | −294K-87% | 2.9M-182% | −548K-84% | −1.6M-40% | −2.2M | −3.5M | −3.5M | −2.7M |
| 淨利率 | -2,543.3% | -3,048.1% | -24,356.2% | -24.9% | -26.4% | 160.0% | -23.9% | -81.2% | -112.8% | -164.0% | -155.0% | -116.4% |
| 稀釋 EPS | -0.10-100% | -0.15-100% | -3.12-100% | -799.90+774% | -761.59+463% | -4355.36+7237% | -1419.10+131298% | -91.56+5769% | -135.37 | -59.36 | -1.08 | -1.56 |
| 稀釋股數 | – | 6.7M | 2.8M | 1.2M | 386 | 241 | 386 | 17.4K | 16.2K | 59.5K | 3.2M | 1.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 7.9M | 8.8M | 5.7M | 383K | 2.5M | 102K | 743K | 12K | 2.4M | 1.4M | 4.6M | 9.0M |
| 應收帳款 | 2K | 309.00 | 23K | 341.00 | 700K | 2K | 1.3M | 1.4M | 1.6M | – | – | – |
| 存貨 | – | – | – | 2.6M | 2.5M | 2.5M | 2.9M | 3.2M | 3.5M | 3.2M | 3.3M | 3.5M |
| 總資產 | 9.2M | 10.2M | 7.0M | 1.6M | 1.4M | 1.4M | 1.3M | 1.4M | 8.2M | 7.8M | 11.9M | 16.4M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 1.9M | 2.1M | 3.1M | 6.6M | 5.3M | 5.8M | 4.1M | 3.4M | 3.7M | 4.7M | 5.1M | 8.6M |
| 股東權益 | 7.3M | 8.0M | 2.5M | −5.0M | 1.2M | −4.4M | 1.5M | −4.0M | 4.5M | 3.1M | 6.7M | 7.8M |
| 負債比 | 20.3% | 21.1% | 44.4% | 407.2% | 364.0% | 417.8% | 322.9% | 243.6% | 44.9% | 60.6% | 43.1% | 52.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.4M | – | – | −204K-90% | – | – | – | −2.1M | – | – | −5.1M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | 7K |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | −5.1M |
| 折舊攤銷 | 3K | 3K | 3K | 3K | 4K | – | 4K | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | -221.6% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 320K
| Pharmaceutical | 320K | 100.0% | +24.4% |
|---|
產品／服務2025 年度 · 320K
| 產品 | 175K | 54.6% | +29.9% |
|---|---|---|---|
| License | 117K | 36.6% | – |
| Royalty | 28K | 8.8% | -40.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 320K | -96.0% | −10.3M | -3,209.7% | -4.86 | – |
| FY2024 | 8.0M | -7.7% | −1.4M | -18.1% | -6001.39 | – |
| FY2023 | 8.7M | -22.8% | −11.4M | -131.2% | -110.87 | −17.0M |
| FY2022 | 11.2M | -17.4% | −46.2M | -411.2% | -108.90 | −22.0M |
| FY2021 | 13.6M | +20.4% | −63.1M | -464.3% | -288.97 | −15.7M |
| FY2020 | 11.3M | +244.4% | −21.6M | -191.4% | -5.55 | −8.7M |
| FY2019 | 3.3M | -63.9% | −23.7M | -721.6% | -5.03 | −23.1M |
| FY2018 | 9.1M | – | −37.4M | -410.7% | -19.64 | −30.7M |